nbsp, Ceredase and Cerezyme, changed the lives of Gaucher disease patients, but the Ceredase price has changed the lives beyond Gaucher patients. It was proof of a viable business model.

Genzyme of Cambridge, Massachusetts, faces millions in lost revenue from its top-selling specialty drugs Cerezyme and Fabrazyme as result of a viral contamination at its Allston, Massachusetts plant.

Genzyme originally launched Ceredase (placenta-derived GCR) in 1991, which was followed by the approval of Cerezyme (recombinant GCR) in 1994. Since that time, sales have grown steadily at a 28% ...

which is enzyme replacement therapy such as Genzyme’s own Cerezyme (imiglucerase). Information from NICE shows that the list price of Cerdelga is £342.23 per capsule, bringing the total cost to ...

The Delhi HC directed that the Centre establish a National Fund for Rare Diseases and allocate Rs 974 crore for 2024-25 and ...